MICHELLE THARP: Open Payments
NPI 1720528011 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$21,864 in 55 payments from 10 companies in 2025. Trend: 2023 $51 · 2024 $5,364 · 2025 $21,864
Speaker / faculty: $11,715Travel & lodging: $5,359Consulting: $3,458Food & beverage: $1,182Honoraria: $150
| Company | Payments | Amount |
|---|---|---|
| BioMarin Pharmaceutical Inc. | 33 | $18,894 |
| PTC Therapeutics, Inc. | 5 | $1,441 |
| Chiesi USA, Inc. | 3 | $1,035 |
| GENZYME CORPORATION | 5 | $213 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $89 |
| Ultragenyx Pharmaceutical Inc. | 2 | $53 |
| Orchard Therapeutics North America | 1 | $44 |
| Zevra Therapeutics Inc | 1 | $43 |
| Cycle Pharmaceuticals Inc | 1 | $37 |
| IntraBio Inc | 1 | $15 |
Products named: Palynziq, SEPHIENCE, ELFABRIO, LAMZEDE, FABRAZYME, Kuvan, Dojolvi, ELAPRASE.
Industry payments across MS — which companies pay providers there.
